International Programs
The Proctor Foundation was founded in 1947 for the specific aim of eradicating trachoma worldwide. Since that time, it has evolved into a major research and teaching unit at UCSF, with the Foundation’s goal remaining the prevention and treatment of blindness worldwide. The International Programs division at Proctor has taken over the original goal of the foundation and has focused on the prevention of blindness programs around the world.
Adalimumab in Juvenile Idiopathic Arthritis-associated Uveitis Stopping Trial (ADJUST)
A randomized, controlled trial evaluating the feasibility of discontinuing adalimumab in patients with quiescent JIA-associated uveitis.
For more please visit: Link
Comprehensive Analysis of Pathogens, Resistomes, and Inflammatory-markers in the CORNea (CapriCORN)
This study identifies pathogens and provides regional AMR profiles to improve diagnostics and treatment for infectious keratitis.
For more please visit: Link
Use of Serosurveillance to Support the Trachoma Elimination Endgame
This NIH-funded study uses antibodies in blood to track Chlamydia trachomatis transmission among children globally, supporting trachoma elimination through WHO guidelines.
For more please visit: Link
Leveraging Ocular Tissues in Uveitis Study (LOTUS)
A global initiative applying high-throughput sequencing to improve classification, diagnosis, and biomarker discovery for infectious uveitis.
For more please visit: Link
Ocular Rosacea microBiome Study (ORBS)
A randomized clinical trial exploring dosing strategies of doxycycline to improve treatment of symptomatic ocular rosacea.
For more please visit: Link
Remote Dry Eye Feasibility Study
Explores remote participation in dry eye research using at-home surveys and self-administered tear collection kits.
For more please visit: Link
Steroids and Cross-linking for Ulcer Treatment (SCUT II)
Evaluates CXL vs. antimicrobial treatments in a multi-site bacterial keratitis trial including India and the U.S.
For more please visit: Link
Trachoma Laboratory Surveillance & Diagnostics
The Proctor Foundation lab collaborates to design and optimize molecular assays supporting trachoma eradication strategies across endemic regions.
PI: Proctor Foundation Laboratory Team
Village Integrated Eye Worker (VIEW) Trial I & II
Cluster-randomized trials testing the effectiveness of early intervention and diagnostic screening by trained community health volunteers to reduce corneal ulceration and visual impairment in rural areas.
PI: Thomas M. Lietman, MD & Jeremy Keenan, MD, MPH
For more please visit: Trial I, Trial II